Annual EBITDA
-$119.69 M
+$15.15 M+11.24%
31 December 2023
Summary:
Kronos Bio annual earnings before interest, taxes, depreciation & amortization is currently -$119.69 million, with the most recent change of +$15.15 million (+11.24%) on 31 December 2023. During the last 3 years, it has fallen by -$35.98 million (-42.98%). KRON annual EBITDA is now -1726.27% below its all-time high of -$6.55 million, reached on 31 December 2018.KRON EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$15.30 M
+$1.72 M+10.11%
30 September 2024
Summary:
Kronos Bio quarterly earnings before interest, taxes, depreciation & amortization is currently -$15.30 million, with the most recent change of +$1.72 million (+10.11%) on 30 September 2024. Over the past year, it has increased by +$18.01 million (+54.06%). KRON quarterly EBITDA is now -290.21% below its all-time high of -$3.92 million, reached on 30 September 2019.KRON Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$80.84 M
+$18.01 M+18.22%
30 September 2024
Summary:
Kronos Bio TTM earnings before interest, taxes, depreciation & amortization is currently -$80.84 million, with the most recent change of +$18.01 million (+18.22%) on 30 September 2024. Over the past year, it has increased by +$42.18 million (+34.28%). KRON TTM EBITDA is now -1961.30% below its all-time high of -$3.92 million, reached on 30 September 2019.KRON TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KRON EBITDA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +11.2% | +54.1% | +34.3% |
3 y3 years | -43.0% | +53.8% | +32.9% |
5 y5 years | -1726.3% | -290.2% | -1961.3% |
KRON EBITDA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -43.0% | +19.9% | at high | +75.3% | at high | +50.6% |
5 y | 5 years | -1726.3% | +19.9% | -290.2% | +75.3% | -1961.3% | +50.6% |
alltime | all time | -1726.3% | +19.9% | -290.2% | +75.3% | -1961.3% | +50.6% |
Kronos Bio EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$15.30 M(-10.1%) | -$80.84 M(-18.2%) |
June 2024 | - | -$17.02 M(-9.1%) | -$98.86 M(-10.5%) |
Mar 2024 | - | -$18.73 M(-37.1%) | -$110.50 M(-7.7%) |
Dec 2023 | -$119.69 M(-11.2%) | -$29.78 M(-10.6%) | -$119.69 M(-2.7%) |
Sept 2023 | - | -$33.31 M(+16.2%) | -$123.02 M(+0.3%) |
June 2023 | - | -$28.67 M(+2.7%) | -$122.67 M(-3.4%) |
Mar 2023 | - | -$27.92 M(-15.7%) | -$126.97 M(-5.8%) |
Dec 2022 | -$134.85 M(-9.8%) | -$33.11 M(+0.4%) | -$134.85 M(-17.6%) |
Sept 2022 | - | -$32.97 M(+0.0%) | -$163.60 M(-0.1%) |
June 2022 | - | -$32.97 M(-7.9%) | -$163.78 M(+2.7%) |
Mar 2022 | - | -$35.81 M(-42.1%) | -$159.50 M(+6.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$149.42 M(+78.5%) | -$61.86 M(+86.6%) | -$149.42 M(+24.1%) |
Sept 2021 | - | -$33.15 M(+15.6%) | -$120.42 M(-2.0%) |
June 2021 | - | -$28.68 M(+11.4%) | -$122.90 M(+19.8%) |
Mar 2021 | - | -$25.73 M(-21.7%) | -$102.61 M(+22.6%) |
Dec 2020 | -$83.72 M(+431.3%) | -$32.86 M(-7.8%) | -$83.72 M(+49.0%) |
Sept 2020 | - | -$35.63 M(+324.3%) | -$56.18 M(+129.5%) |
June 2020 | - | -$8.40 M(+22.9%) | -$24.48 M(+52.2%) |
Mar 2020 | - | -$6.83 M(+28.4%) | -$16.08 M(+73.9%) |
Dec 2019 | -$15.76 M(+140.4%) | -$5.32 M(+35.7%) | -$9.25 M(+135.7%) |
Sept 2019 | - | -$3.92 M | -$3.92 M |
Dec 2018 | -$6.55 M | - | - |
FAQ
- What is Kronos Bio annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Kronos Bio?
- What is Kronos Bio annual EBITDA year-on-year change?
- What is Kronos Bio quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Kronos Bio?
- What is Kronos Bio quarterly EBITDA year-on-year change?
- What is Kronos Bio TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Kronos Bio?
- What is Kronos Bio TTM EBITDA year-on-year change?
What is Kronos Bio annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of KRON is -$119.69 M
What is the all time high annual EBITDA for Kronos Bio?
Kronos Bio all-time high annual earnings before interest, taxes, depreciation & amortization is -$6.55 M
What is Kronos Bio annual EBITDA year-on-year change?
Over the past year, KRON annual earnings before interest, taxes, depreciation & amortization has changed by +$15.15 M (+11.24%)
What is Kronos Bio quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of KRON is -$15.30 M
What is the all time high quarterly EBITDA for Kronos Bio?
Kronos Bio all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$3.92 M
What is Kronos Bio quarterly EBITDA year-on-year change?
Over the past year, KRON quarterly earnings before interest, taxes, depreciation & amortization has changed by +$18.01 M (+54.06%)
What is Kronos Bio TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of KRON is -$80.84 M
What is the all time high TTM EBITDA for Kronos Bio?
Kronos Bio all-time high TTM earnings before interest, taxes, depreciation & amortization is -$3.92 M
What is Kronos Bio TTM EBITDA year-on-year change?
Over the past year, KRON TTM earnings before interest, taxes, depreciation & amortization has changed by +$42.18 M (+34.28%)